Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMDC-USR in Female Stress Urinary Incontinence (Japan)
NCT03997318Phase 3Withdrawn
- Sponsor
- Cook MyoSite
- Start
- Jun 2025
- Primary completion
- Jun 2026
- Modality
- Cell Therapies
01
Overview
Phase 3, randomised, double-blind trial in stress urinary incontinence (SUI) comparing AMDC-USR with Placebo (2 arms). Primary endpoint: Number of leaks due to stress incontinence episodes at 12 months. Planned start Jun 2025; status: withdrawn.
02
Drugs
AMDC-USR
03
Conditions
stress urinary incontinence (SUI)
Beyond the preview
Go deeper on NCT03997318.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03997318.